1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
The Toro Company said its board elected President and Chief Operating Officer Edric C. Funk as president and chief executive officer, effective November 1, 2026, as part of a planned succession. Richard M. Olson, CEO since November 2016, will become executive chairman on the same date, and Funk joined the board immediately.
Funk was elected by the board on July 21, 2026, joined the company in 1996, and has been president and COO since September 2025.
Funk's annual base salary rises from $715,000 to $1,000,000 effective November 1, 2026, with a fiscal 2027 cash incentive target of 120% of base salary.
Olson's base salary will be $763,000 as executive chairman, with a fiscal 2027 cash incentive target of 130% of base salary, effective November 1, 2026.
The board increased its size from nine to ten directors to seat Funk, whose term ends at the 2027 annual meeting.
Trane Technologies said its Senior Vice President and Chief Global Integrated Supply Chain Officer, Mingxiao (Gary) Guo, will leave the company effective August 1, 2026, under a separation agreement. The filing says the departure is not the result of any disagreement with the company on operations, policies, practices, controls or financial matters.
Mingxiao (Gary) Guo's departure is effective August 1, 2026; the decision was made July 20, 2026.
Under the separation agreement, the company is forgoing the clawback of certain sign-on bonus payments made to Mr. Guo.
The filing states the departure is not due to any disagreement on operations, policies, practices, controls or financial matters.
Quantum Computing Inc. appointed Susan G. Hunt as Chief Revenue Officer effective July 17, 2026, succeeding Pouya Dianat, who moved to the newly created Chief Product Officer role. The filing says the move was mutually agreed and that Dianat's compensation was not materially changed. Hunt will lead the company's global revenue strategy, sales execution, and customer growth initiatives as it works to commercialize quantum computing solutions.
Susan G. Hunt, age 64, became Chief Revenue Officer on July 17, 2026, succeeding Pouya Dianat.
Dianat transitioned from CRO to the newly created Chief Product Officer role, effective immediately, focusing on product development.
Hunt previously served as CRO of Orbital Insight from May 2022 to January 2023 and as Senior Vice President of North American Sales at LivePerson from January 2019 to October 2022.
The filing says Dianat's compensation was not materially changed in connection with the transition.
NewHold Investment Corp IV said Chief Financial Officer Polly Schneck resigned effective July 22, 2026, to pursue other professional opportunities, and the board appointed John Boone as CFO effective the same day. The filing says her departure was not due to any disagreement with the company, its board or management. Compensation for Mr. Boone has not been finalized and will be disclosed later if required.
Polly Schneck resigned as CFO effective July 22, 2026; the filing states no disagreement on operations, policies or practices
John Boone appointed CFO effective July 22, 2026, with over a decade of public equity investing experience
Mr. Boone previously worked at Isomer Partners, Schonfeld Strategic Advisors and Scopia Capital Management
Compensation arrangements for Mr. Boone have not been finalized
Jackson Financial said its board approved Don Cummings as chief executive officer, president and director, and Brian Walta as executive vice president and chief financial officer, both effective October 1, 2026. CEO Laura Prieskorn will retire from her roles and as a director at the end of September 30, 2026, and will serve as an advisor through December 31, 2026. The filing reports pay terms for both new executives but no changes to financial results or guidance.
Don Cummings, currently CFO, becomes CEO and president effective October 1, 2026, with a base salary of $1.05 million, a 200% target bonus and a $7.85 million target long-term incentive award.
Laura Prieskorn retires as CEO, president and director at the end of September 30, 2026, and is expected to advise the company through December 31, 2026.
Rayonier Advanced Materials said its Senior Vice President, General Counsel and Corporate Secretary, R. Colby Slaughter, notified the company on July 20, 2026 that he will resign effective August 7, 2026, to pursue another professional opportunity. The filing does not name a successor or interim replacement.
Colby Slaughter, Senior Vice President, General Counsel and Corporate Secretary, gave notice on July 20, 2026.
Resignation takes effect August 7, 2026.
He is leaving to pursue another professional opportunity; no successor is named in the filing.
Guidewire's board appointed Alexander Vollert, a former chief operating officer of AXA SA, as a director effective August 1, 2026. The filing also discloses that Guidewire recognized revenue from AXA SA and its affiliates in fiscal 2025 and in the nine months ended April 30, 2026, which is relevant because Dr. Vollert was an AXA executive until December 2025.
Board appointment made July 17, 2026, effective August 1, 2026; initial term runs through the 2026 annual meeting, subject to re-election.
Dr. Vollert was chief operating officer of AXA SA from December 2021 to December 2025 and CEO of AXA Germany from September 2016 to November 2021.
Guidewire recognized about $13.4 million in revenue from AXA SA and affiliates for the nine months ended April 30, 2026, and about $11.3 million in fiscal 2025 (year ended July 31, 2025).
American Healthcare REIT said Danny Prosky retired as CEO and President effective July 21, 2026, and the board named Jeff Hanson CEO that day; Hanson, who had been interim CEO since February 2026, also remains Chairman. Prosky stays on the board, and Gabe Willhite was elevated to President while remaining Chief Operating Officer, which changes who runs day-to-day operations and sets new pay terms for the top executives.
Jeff Hanson named CEO effective July 21, 2026; he continues as Chairman. His base salary is $965,000 and his target annual bonus is 160% of base salary.
Hanson received two equity grants, each with a grant date fair value of $2,072,534: time-based RSUs vesting over three years and performance-based RSUs cliff-vesting December 31, 2028.
Danny Prosky's release of claims agreement provides a $35,000 lump sum for continuation medical coverage and accelerated vesting of an unvested restricted stock award scheduled to vest February 9, 2028.
Gabe Willhite was named President and Chief Operating Officer, with a $100,000 cash pay increase and target bonus raised to 125% of base pay; Scott Estes was named Lead Independent Director with a $40,000 added annual retainer.
Target's Board of Directors elected Joe DePinto, former president and CEO of 7-Eleven, Inc., as a director on July 18, 2026, effective August 1, 2026. The filing says he will also serve on the Audit & Risk Committee and the Infrastructure & Finance Committee and will receive the standard non-employee director pay described in Target's 2026 proxy statement. The filing reports no financial results or other financial figures.
Joe DePinto elected to Target's Board by the Board on July 18, 2026, effective August 1, 2026
Appointed to the Audit & Risk Committee and the Infrastructure & Finance Committee, both effective August 1, 2026
DePinto, 63, was CEO of 7-Eleven, Inc. from 2005 to December 2025; the filing names prior roles at GameStop and PepsiCo
Filing states no related person transactions with Target and no arrangements under which he was selected
Intellicheck said Chief Technology Officer Jonathan Robins will leave the company for personal family reasons. He is on unpaid leave from July 18, 2026, and his employment ends October 16, 2026. The filing describes healthcare and COBRA coverage the company will pay for, but it does not name a successor or cite any financial impact.
Jonathan Robins notified the company on July 16, 2026 of his decision to separate as Chief Technology Officer, effective July 18, 2026.
Robins is on unpaid leave from July 18, 2026; his final day of employment is October 16, 2026.
The company will pay the full cost of Robins's benefits during leave and COBRA continuation coverage from November 1, 2026 through March 31, 2027.
The full memorandum of understanding will be filed with the quarterly report for the quarter ended September 30, 2026.
Shenandoah Telecommunications said Vice President and Chief Accounting Officer Tracy Willis notified the company on July 20, 2026 that she will resign effective August 6, 2026. CFO James Volk will take on the role of principal accounting officer while continuing as principal financial officer, and the filing states her departure was not due to any disagreement with the company.
Tracy Willis, Vice President and Chief Accounting Officer, notified the company of her resignation on July 20, 2026
Resignation is effective August 6, 2026
James Volk, Senior Vice President and CFO, will become principal accounting officer upon her departure and keep the principal financial officer role
The filing states the departure was not the result of any disagreement with the company
Corvus Pharmaceuticals said director Ian T. Clark gave notice on July 21, 2026 that he will resign from its board, effective July 22, 2026. The company thanked him for more than nine years of board service, and the filing gives no replacement or reason for the departure.
Ian T. Clark delivered resignation notice on July 21, 2026.
Resignation is effective July 22, 2026.
Clark served on the board for over nine years, according to the company.
Credit Acceptance said director Kenneth S. Booth resigned from its board on July 21, 2026, and that the resignation was not due to any disagreement with the company, management, or the board. The board reduced its size from six directors to five in connection with his departure.
Kenneth S. Booth notified the company of his board resignation on July 21, 2026.
The filing states the resignation was not due to any disagreement with the company, its management, the Board or any committee.
The board size was reduced from six directors to five.
Red Cat Holdings' board determined that Chief Revenue Officer Geoffrey Hitchcock was terminated for cause, effective July 23, 2026, and that he is not entitled to severance or accelerated equity vesting. On July 21, 2026, Mr. Hitchcock filed a civil complaint against the company seeking damages in an unspecified amount, which the company says is without merit.
Termination of Chief Revenue Officer Geoffrey Hitchcock is effective July 23, 2026, based on a for-cause determination made July 17, 2026.
Mr. Hitchcock is not entitled to severance or acceleration of equity vesting, except for salary and benefits earned through the termination date.
Mr. Hitchcock filed a civil complaint on July 21, 2026, alleging retaliatory termination, breach of contract and breach of the implied covenant of good faith; damages are unspecified.
The company says the claims are without merit and will evaluate potential counterclaims.
Inspire Medical Systems said director Casey Tansey, a board member for more than eighteen years, will retire from the board effective July 30, 2026, and will not stand for re-election at the 2027 Annual Meeting. The company said the decision was not the result of any disagreement with the company or any matter relating to its operations, policies or practices, and it expects to name a replacement director in the near future.
Casey Tansey's retirement from the board and its committees is effective July 30, 2026.
Tansey led the Series A financing in November 2007 for U.S. Venture Partners and has served on the board since then.
The company said it expects to announce a new director to replace Tansey in the near future.
FirstCash Holdings announced that CEO and Vice Chairman Rick Wessel will become Executive Chairman and step down as CEO effective January 1, 2027, with President and COO Brent Stuart succeeding him as CEO on that date. The board also elected Stuart as a director effective July 22, 2026, and Chairman Dan Feehan will retire from the chairmanship on the transition date while remaining on the board. Stuart's and Wessel's compensation has not yet been determined and will be disclosed in a future amendment.
Rick Wessel moves from CEO to Executive Chairman effective January 1, 2027, and expects to serve on the board for at least three years.
Brent Stuart, 56, President and COO since September 2016, will become CEO effective January 1, 2027, and keep direct responsibility for day-to-day operations.
Stuart was elected to the board effective July 22, 2026, and will not receive separate board compensation.
Dan Feehan will retire as Chairman of the Board on January 1, 2027, and remain a board member.
BD said Executive Vice President Michael Garrison, president of the Medical Essentials and BioPharma Systems segments, will retire after more than 20 years with the company. BD is searching for his successor as president of Medical Essentials, and BioPharma Systems will report directly to CEO Tom Polen to streamline the operating model.
Garrison informed BD of his retirement intention on July 19, 2026, and the press release gives an effective date of Oct. 2.
The filing says Garrison will stay in his role through the end of the fiscal year to support a smooth transition.
A comprehensive search is underway for the next president of Medical Essentials.
BioPharma Systems will report directly to Chairman, CEO and President Thomas E. Polen.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.